<VariationArchive VariationID="166741" VariationName="NM_000709.4(BCKDHA):c.117dup (p.Arg40fs)" VariationType="Duplication" Accession="VCV000166741" Version="20" RecordType="classified" NumberOfSubmissions="11" NumberOfSubmitters="11" DateLastUpdated="2024-06-23" DateCreated="2017-03-08" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="177515" VariationID="166741">
      <GeneList>
        <Gene Symbol="BCKDHA" FullName="branched chain keto acid dehydrogenase E1 subunit alpha" GeneID="593" HGNC_ID="HGNC:986" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19q13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="41397818" stop="41425002" display_start="41397818" display_stop="41425002" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="41903693" stop="41930909" display_start="41903693" display_stop="41930909" Strand="+" />
          </Location>
          <OMIM>608348</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000709.4(BCKDHA):c.117dup (p.Arg40fs)</Name>
      <CanonicalSPDI>NC_000019.10:41410638:CCCCCCC:CCCCCCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>19q13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="41410638" stop="41410639" display_start="41410638" display_stop="41410639" variantLength="1" positionVCF="41410638" referenceAlleleVCF="A" alternateAlleleVCF="AC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="41916543" stop="41916544" display_start="41916543" display_stop="41916544" variantLength="1" positionVCF="41916543" referenceAlleleVCF="A" alternateAlleleVCF="AC" />
      </Location>
      <ProteinChange>R40fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.41410645dup" Assembly="GRCh38">
            <Expression>NC_000019.10:g.41410645dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.41916550dup" Assembly="GRCh37">
            <Expression>NC_000019.9:g.41916550dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_013004.1" sequenceAccession="NG_013004" sequenceVersion="1" change="g.17857dup">
            <Expression>NG_013004.1:g.17857dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000709.4" sequenceAccession="NM_000709" sequenceVersion="4" change="c.117dup" MANESelect="true">
            <Expression>NM_000709.4:c.117dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000700.1" sequenceAccession="NP_000700" sequenceVersion="1" change="p.Arg40fs">
            <Expression>NP_000700.1:p.Arg40fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001164783.2" sequenceAccession="NM_001164783" sequenceVersion="2" change="c.117dup">
            <Expression>NM_001164783.2:c.117dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001158255.1" sequenceAccession="NP_001158255" sequenceVersion="1" change="p.Arg40fs">
            <Expression>NP_001158255.1:p.Arg40fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000709.3" sequenceAccession="NM_000709" sequenceVersion="3" change="c.117dup">
            <Expression>NM_000709.3:c.117dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000709.4" sequenceAccession="NM_000709" sequenceVersion="4" change="c.110_111insC" MANESelect="true">
            <Expression>NM_000709.4:c.110_111insC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA295587" DB="ClinGen" />
        <XRef Type="rs" ID="398123489" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000709.4(BCKDHA):c.117dup (p.Arg40fs) AND not provided" Accession="RCV000152848" Version="10">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2017-01-20" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000709.4(BCKDHA):c.117dup (p.Arg40fs) AND Maple syrup urine disease" Accession="RCV000984155" Version="13">
        <ClassifiedConditionList TraitSetID="6467">
          <ClassifiedCondition DB="MedGen" ID="C0024776">Maple syrup urine disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-11" SubmissionCount="6">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000709.4(BCKDHA):c.117dup (p.Arg40fs) AND Maple syrup urine disease type 1A" Accession="RCV001826819" Version="2">
        <ClassifiedConditionList TraitSetID="9391">
          <ClassifiedCondition DB="MedGen" ID="C1855369">Maple syrup urine disease type 1A</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-02-26" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000709.4(BCKDHA):c.117dup (p.Arg40fs) AND Inborn genetic diseases" Accession="RCV002516069" Version="2">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-03-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-26" NumberOfSubmissions="11" NumberOfSubmitters="11" DateCreated="2017-03-08" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16468966</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16786533</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22593002</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22727569</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25333063</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31998365</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8037208</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9582350</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=BCKDHA</URL>
        </Citation>
        <ConditionList>
          <TraitSet ID="9391" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9026" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Maple syrup urine disease type 1A</ElementValue>
                <XRef ID="Maple+syrup+urine+disease+type+1A/4455" DB="Genetic Alliance" />
                <XRef ID="MONDO:0023691" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MSUD type 1A</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MSUD1A</ElementValue>
                <XRef Type="MIM" ID="248600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8594" />
                <XRef ID="8594" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301495</ID>
                <ID Source="BookShelf">NBK1319</ID>
              </Citation>
              <XRef ID="C1855369" DB="MedGen" />
              <XRef ID="MONDO:0023691" DB="MONDO" />
              <XRef Type="MIM" ID="248600" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6467" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2822" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Maple syrup urine disease</ElementValue>
                <XRef ID="Maple+syrup+urine+disease/4453" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009563" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS248600" DB="OMIM" />
                <XRef ID="511" DB="Orphanet" />
                <XRef ID="27718001" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MSUD</ElementValue>
                <XRef Type="MIM" ID="248600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Maple syrup urine disease (MSUD) is categorized as classic (severe), intermediate, or intermittent. Neonates with classic MSUD are born asymptomatic but without treatment follow a predictable course: 12–24 hours. Elevated concentrations of branched-chain amino acids (BCAAs; leucine, isoleucine, and valine) and alloisoleucine, as well as a generalized disturbance of amino acid concentration ratios, are present in blood and the maple syrup odor can be detected in cerumen; Two to three days. Early and nonspecific signs of metabolic intoxication (i.e., irritability, hypersomnolence, anorexia) are accompanied by the presence of branched-chain alpha-ketoacids, acetoacetate, and beta-hydroxybutyrate in urine; Four to six days. Worsening encephalopathy manifests as lethargy, apnea, opisthotonos, and reflexive "fencing" or "bicycling" movements as the sweet maple syrup odor becomes apparent in urine; Seven to ten days. Severe intoxication culminates in critical cerebral edema, coma, and central respiratory failure. Individuals with intermediate MSUD have partial branched-chain alpha-ketoacid dehydrogenase deficiency that manifests only intermittently or responds to dietary thiamine therapy; these individuals can experience severe metabolic intoxication and encephalopathy in the face of sufficient catabolic stress. In the era of newborn screening (NBS), the prompt initiation of treatment of asymptomatic infants detected by NBS means that most individuals who would have developed neonatal manifestations of MSUD remain asymptomatic with continued treatment compliance.</Attribute>
                <XRef ID="NBK1319" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3228" />
                <XRef ID="3228" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000505125" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570054" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000561777" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528449" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521391" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522317" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000505096" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522527" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528448" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592960" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000519087" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529111" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301495</ID>
                <ID Source="BookShelf">NBK1319</ID>
              </Citation>
              <Citation Type="general" Abbrev="GMDI/SERC, 2014">
                <ID Source="PubMed">24881969</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2011">
                <URL>http://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Carrier-Screening-ACT-SheetAshkenazi-Jewish-Genetic-Disorders.aspx</URL>
                <CitationText>American College of Medical Genetics ACT Sheet, Carrier Screening ACT Sheet Ashkenazi Jewish Genetic Disorders</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="GMDI/SERN, 2021">
                <URL>https://managementguidelines.net/guidelines.php/129/MSUD%20Nutrition%20Guidelines/Version%201.58</URL>
                <CitationText>MSUD Nutrition Management Guidelines</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2021">
                <URL>https://www.acmg.net/PDFLibrary/Leucine.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Increased Leucine, Maple Syrup Urine Disease, 2021</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2021">
                <URL>https://www.acmg.net/PDFLibrary/Leucine-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Leucine Elevated, 2021</CitationText>
              </Citation>
              <XRef ID="511" DB="Orphanet" />
              <XRef ID="C0024776" DB="MedGen" />
              <XRef ID="D008375" DB="MeSH" />
              <XRef ID="MONDO:0009563" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS248600" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1372694" SubmissionDate="2017-06-30" DateLastUpdated="2019-07-31" DateCreated="2018-04-02">
        <ClinVarSubmissionID localKey="1439_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000700309" DateUpdated="2019-07-31" DateCreated="2018-04-02" Type="SCV" Version="2" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-12-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions</Attribute>
          <Citation>
            <URL>http://www.egl-eurofins.com/emvclass/EGLClassificationDefinitions.php</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="3" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="3" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BCKDHA" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="19" alternateAllele="CC" referenceAllele="C" start="41916550" stop="41916550" variantLength="1" />
            <GeneLocation>NM_000709.3:Ex2</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CI941839" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=BCKDHA</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>EGL005</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5444025" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_000709.4:c.117dup|OMIM:248600" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002789158" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000709.4:c.117dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="248600" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6242032" SubmissionDate="2024-04-19" DateLastUpdated="2024-05-01" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="a9691093|MedGen:C0950123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003554339" DateUpdated="2024-05-01" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-03-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">8037208</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16468966</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22727569</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25333063</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31998365</ID>
          </Citation>
          <Comment>The c.117dupC (p.R40Qfs*11) alteration, located in exon 2 (coding exon 2) of the BCKDHA gene, consists of a duplication of C at position 117, causing a translational frameshift with a predicted alternate stop codon after 11 amino acids. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on data from the Genome Aggregation Database (gnomAD) database, the BCKDHA c.117dupC alteration was observed in 0.0024% (6/250,846) of total alleles studied, with a frequency of 0.0044% (5/113,326) in the European (non-Finnish) subpopulation. This alteration has been identified with a second alteration in BCKDHA in several unrelated patients with intermediate or classic maple syrup urine disease (Chuang, 1994, Fernandez-Guerra, 2014, Zhang, 2019). Based on the available evidence, this alteration is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BCKDHA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000709.3:c.117dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>AVA4 Submission_Through01042023</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava4_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7862056" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000709.4:c.117dup|OMIM:248600" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004215865" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000709.4:c.117dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="248600" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="441886" SubmissionDate="2019-01-29" DateLastUpdated="2017-03-08" DateCreated="2015-07-18">
        <ClinVarSubmissionID localKey="GDX:6484|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000238736" DateUpdated="2017-03-08" DateCreated="2015-07-18" Type="SCV" Version="5" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-01-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.117dupC pathogenic variant in the the BCKDHA gene has previously reported been reported in association with maple syrup urine disease (Jacinta et al., 1994; FernÃ¡ndez-Guerra et al., 2014). The duplication causes a frameshift starting with codon Arginine 40, changes this amino acid to a Glutamine residue and creates a premature Stop codon at position 11 of the new reading frame, denoted p.Arg40GlnfsX11. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BCKDHA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="19" alternateAllele="CC" referenceAllele="C" start="41916550" stop="41916551" variantLength="2" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000709.3:c.117dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2235206" SubmissionDate="2019-08-05" DateLastUpdated="2019-12-23" DateCreated="2019-12-23">
        <ClinVarSubmissionID localKey="25535|OMIM:248600" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001132138" DateUpdated="2019-12-23" DateCreated="2019-12-23" Type="SCV" Version="1" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-01-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16786533</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9582350</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BCKDHA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="19" alternateAllele="AC" referenceAllele="A" start="41916543" stop="41916543" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="248600" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6133108</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2671621" SubmissionDate="2020-03-06" DateLastUpdated="2020-06-22" DateCreated="2020-06-22">
        <ClinVarSubmissionID localKey="NM_000709.3:c.117dup|MedGen:C0024776" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001363272" DateUpdated="2020-06-22" DateCreated="2020-06-22" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-12-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16786533</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8037208</ID>
          </Citation>
          <Comment>Variant summary: BCKDHA c.117dupC (p.Arg40GlnfsX11) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 2.4e-05 in 250846 control chromosomes (gnomAD). c.117dupC has been reported in the literature in individuals affected with Maple syrup urine disease (Chuang _1994, Rodriguez-Pombo_2006). In addition, Rodriguez-Pombo_2006 reports variant effect results in &lt;10% of normal BCKD activity. These data indicate that the variant may be associated with disease.Two ClinVar submitters (evaluation after 2014) cite the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BCKDHA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000709.3:c.117dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Maple syrup urine disease</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0024776" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6913290</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3988677" SubmissionDate="2021-12-15" DateLastUpdated="2021-12-18" DateCreated="2021-12-18">
        <ClinVarSubmissionID localKey="NM_000709.4:c.117dup|OMIM:248600" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002033328" DateUpdated="2021-12-18" DateCreated="2021-12-18" Type="SCV" Version="1" SubmitterName="Genome-Nilou Lab" OrgID="507598" OrganizationCategory="laboratory" OrgAbbreviation="Genome Nilou" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-11-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BCKDHA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000709.4:c.117dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="248600" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10805773</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4086600" SubmissionDate="2022-02-09" DateLastUpdated="2022-02-13" DateCreated="2022-02-13">
        <ClinVarSubmissionID localKey="NM_000709.4:c.117dup|Maple syrup urine disease type 1A" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002088137" DateUpdated="2022-02-13" DateCreated="2022-02-13" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-07-20">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000709.4:c.117dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Maple syrup urine disease type 1A</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10993736</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7339901" SubmissionDate="2023-05-24" DateLastUpdated="2023-05-27" DateCreated="2023-05-27">
        <ClinVarSubmissionID localKey="SUB13453807" submittedAssembly="hg19" title="SUB13453807" />
        <ClinVarAccession Accession="SCV003926495" DateUpdated="2023-05-27" DateCreated="2023-05-27" Type="SCV" Version="1" SubmitterName="Lifecell International Pvt. Ltd" OrgID="507720" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">16786533</ID>
          </Citation>
          <Comment>A Heterozygous Frameshift, Splice site region variant c.110_111insC in Exon 2 of the BCKDHA gene that results in the amino acid substitution p.Arg40fs*11 was identified. The observed variant has a maximum allele frequency of 0.00002% in gnomAD exomes and genomes, respectively. This variant has been reported as pathogenic in ClinVar (variant ID: 166741) with 2 stars, criteria. The severity of the impact of this variant on the protein is high, based on the effect of the protein and REVEL score. Rare Exome Variant Ensemble Learner (REVEL) is an ensembl method for predicting the pathogenicity of missense variants based on a combination of scores from 13 individual tools: MutPred, FATHMM v2.3, VEST 3.0, PolyPhen-2, SIFT, PROVEAN, MutationAssessor, MutationTaster, LRT, GERP++, SiPhy, phyloP, and phastCons. The REVEL score for an individual missense variant can range from 0 to 1, with higher scores reflecting greater likelihood that the variant is disease-causing. This variant has previously been reported for MSUD in patients by Rodríguez-Pombo P, et, al., 2006. Based on the above evidence this variant has been classified as Pathogenic according to the ACMG guidelines.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Asian</Ethnicity>
              <GeographicOrigin>India</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq 6000</NamePlatform>
              <TypePlatform>Next-generation exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BCKDHA">
              <Name>branched chain keto acid dehydrogenase E1 subunit alpha</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000709.4:exon 2</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="dbSNP" ID="rs398123489" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000709.4:c.110_111insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="248600" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13453807</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2726709" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="4956620|MedGen:C0024776" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001391823" DateUpdated="2024-02-14" DateCreated="2020-07-16" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16786533</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22593002</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8037208</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16786533</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Arg40Glnfs*11) in the BCKDHA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BCKDHA are known to be pathogenic (PMID: 16786533, 22593002). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individuals with maple syrup urine disease (PMID: 8037208, 16786533). ClinVar contains an entry for this variant (Variation ID: 166741). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BCKDHA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.41916543_41916544insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0024776" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2235206" TraitType="Disease" MappingType="XRef" MappingValue="248600" MappingRef="OMIM">
        <MedGen CUI="C1855369" Name="Maple syrup urine disease type 1A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2726709" TraitType="Disease" MappingType="XRef" MappingValue="C0024776" MappingRef="MedGen">
        <MedGen CUI="C0024776" Name="Maple syrup urine disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6242032" TraitType="Disease" MappingType="XRef" MappingValue="C0950123" MappingRef="MedGen">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2671621" TraitType="Disease" MappingType="Name" MappingValue="Maple syrup urine disease" MappingRef="Preferred">
        <MedGen CUI="C0024776" Name="Maple syrup urine disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7339901" TraitType="Disease" MappingType="XRef" MappingValue="248600" MappingRef="OMIM">
        <MedGen CUI="C1855369" Name="Maple syrup urine disease type 1A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4086600" TraitType="Disease" MappingType="Name" MappingValue="Maple syrup urine disease type 1A" MappingRef="Preferred">
        <MedGen CUI="C1855369" Name="Maple syrup urine disease type 1A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7862056" TraitType="Disease" MappingType="XRef" MappingValue="248600" MappingRef="OMIM">
        <MedGen CUI="C1855369" Name="Maple syrup urine disease type 1A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3988677" TraitType="Disease" MappingType="XRef" MappingValue="248600" MappingRef="OMIM">
        <MedGen CUI="C1855369" Name="Maple syrup urine disease type 1A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="441886" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1372694" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5444025" TraitType="Disease" MappingType="XRef" MappingValue="248600" MappingRef="OMIM">
        <MedGen CUI="C1855369" Name="Maple syrup urine disease type 1A" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="2" DateDeleted="2019-07-29">SCV000202244</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

